Contract Reagents, Proteins
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
120
NCT00774813
Nexalin Therapy for the Treatment of Depressive Symptoms
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2007
Completion: May 31, 2008
Loading map...